STRO: Sutro Biopharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 333.72
Enterprise Value ($M) 70.18
Book Value ($M) 98.02
Book Value / Share 1.20
Price / Book 3.40
NCAV ($M) 39.14
NCAV / Share 0.48
Price / NCAV 8.53

Profitability (mra)
Return on Invested Capital (ROIC) -0.84
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.62

Liquidity (mrq)
Quick Ratio 2.85
Current Ratio 2.85

Balance Sheet (mrq) ($M)
Current Assets 344.52
Assets 403.40
Liabilities 305.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 153.73
Operating Income -89.28
Net Income -106.79
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -111.62
Cash from Investing -3.92
Cash from Financing 137.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-05 13G Point72 Asset Management, L.P. 7.90
02-13 13G/A Suvretta Capital Management, Llc 9.50 3.83
02-12 13G/A Rubric Capital Management LP 5.49 4.14
02-07 13G/A Adage Capital Partners Gp, L.l.c. 7.33 25.88
01-24 13G/A BlackRock Inc. 9.60 19.83
01-17 13G Integrated Core Strategies (us) Llc 5.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-25 10-K w, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 112,358 207,996 54.02
2024-05-23 129,945 241,462 53.82
2024-05-22 129,240 335,137 38.56
2024-05-21 243,476 517,898 47.01
2024-05-20 556,570 1,320,642 42.14

(click for more detail)

Similar Companies
SMMT – Summit Therapeutics Inc. SNSE – Sensei Biotherapeutics, Inc.
SPRY – ARS Pharmaceuticals, Inc. SUPN – Supernus Pharmaceuticals, Inc.
TARA – Protara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io